Analysts at Jefferies said the revenue target of $80 billion was widely expected, adding that major new drug catalysts are “somewhat scarce” until 2025.
News
AstraZeneca aims for $80 bln in total revenue by 2030
May 21, 2024Analysts at Jefferies said the revenue target of $80 billion was widely expected, adding that major new drug catalysts are “somewhat scarce” until 2025.